Antimicrobial resistance burden estimates from the bottom-up: research priorities for estimating the impact of antimicrobial resistance in Brazil
- PMID: 39911748
- PMCID: PMC11795537
- DOI: 10.1016/j.ijregi.2024.100558
Antimicrobial resistance burden estimates from the bottom-up: research priorities for estimating the impact of antimicrobial resistance in Brazil
Abstract
Recent estimates of deaths attributable to bacterial antimicrobial resistance (AMR) highlight the immense public health threat of AMR to healthcare systems, economies, and communities in Latin America. Although global modelling studies generate important statistics to motivate and guide global and national agendas, their complex methodology and aggregation mean that they have a more limited impact at the local scales where AMR is experienced and tackled. At the same time, it is increasingly recognised that we need to study and design AMR policies 'from the bottom-up', drawing on data and perspectives that ensure local ownership of the research and policy agenda. But how do we integrate 'bottom-up' perspectives into AMR burden estimation? Brazil is used as a case study to illustrate the importance of this approach. Brazil's vast and decentralised healthcare system would benefit from robust regional estimates of AMR's clinical, economic, and social burdens to move political decision-making and design appropriate interventions. We report on recommendations gathered from interdisciplinary stakeholder exercises and propose strategic priorities for estimating the AMR burden in Brazil at subnational scales of governance. These include focusing on individual-level data linkages at various scales; capturing public and private healthcare systems; understanding AMR inequalities; and capturing linked clinical, economic, and social burdens.
Keywords: Antimicrobial resistance; Brazil; Clinical burden; Policy; Study design.
© 2025 The Authors.
Conflict of interest statement
The authors have no competing interests to declare.
Figures
References
-
- Mendelson M, Laxminarayan R, Limmathurotsakul D, Kariuki S, Gyansa-Lutterodt M, Charani E, et al. Antimicrobial resistance and the great divide: inequity in priorities and agendas between the Global North and the Global South threatens global mitigation of antimicrobial resistance. Lancet Glob Health. 2024;12:e516–e521. doi: 10.1016/S2214-109X(23)00554-5. - DOI - PubMed
-
- Charani E, Mendelson M, Pallett SJC, Ahmad R, Mpundu M, Mbamalu O, et al. An analysis of existing national action plans for antimicrobial resistance-gaps and opportunities in strategies optimising antibiotic use in human populations. Lancet Glob Health. 2023;11:e466–e474. doi: 10.1016/S2214-109X(23)00019-0. - DOI - PubMed
-
- World Health Organization . World Health Organization. Regional Office for Europe; Geneva: 2024. Europe WHORO for People-centred approach to tackling antimicrobial resistance: key principle of the Roadmap on antimicrobial resistance for the WHO European Region 2023–2030.
Publication types
LinkOut - more resources
Full Text Sources